High-volume hemofiltration for septic acute kidney injury: A systematic review and meta-analysis

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Clark, Edward ^a,b   Molnar, Amber O ^a,b   Joannes Boyau, Olivier ^c   Honoré, Patrick M ^d   Sikora, Lindsey ^e   Bagshaw, Sean M ^f  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c HAUT LÉVÊQUE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY INJURY; HEMOFILTRATION; HUMAN; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS;

ACUTE KIDNEY INJURY; HEMOFILTRATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS;

EID: 84892148825     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13184     Document Type: Article

References (49)

1. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546-1554. 10.1056/NEJMoa022139, 12700374.
2. Di Carlo JV, Alexander SR. Hemofiltration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs 2005, 28:777-786.
3. Honore PM, Matson JR. Extracorporeal removal for sepsis: acting at the tissue level-the beginning of a new era for this treatment modality in septic shock. Crit Care Med 2004, 32:896-897. 10.1097/01.CCM.0000115262.31804.46, 15090989.
4. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d'Intini V, Bellomo R. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003, 27:792-801. 10.1046/j.1525-1594.2003.07289.x, 12940901.
5. Atan R, Crosbie D, Bellomo R. Techniques of extracorporeal cytokine removal: a systematic review of the literature. Blood Purif 2012, 33:88-100. 10.1159/000333845, 22248671.
6. Rimmele T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care 2011, 15:205. 10.1186/cc9411, 3222040, 21371356.
7. Cariou A, Vinsonneau C, Dhainaut JF. Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med 2004, 32:S562-S570. 10.1097/01.CCM.0000142910.01076.A5, 15542965.
8. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361:1627-1638.
9. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359:7-20. 2574780, 18492867.
10. Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NK. High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med 2010, 38:1360-1369.
11. Jun M, Heerspink HJ, Ninomiya T, Gallagher M, Bellomo R, Myburgh J, et al. Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2010, 5:956-963. 10.2215/CJN.09111209, 2879310, 20395356.
12. Kellum JA, Ronco C. Dialysis: results of renal-what is the optimal CRRT target dose?. Nat Rev Nephrol 2010, 6:191-192.
13. Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C. The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002, 62:1855-1863.
14. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL. High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 1992, 18:235-240. 10.1007/BF01709839, 1430589.
15. Rogiers P, Zhang H, Smail N, Pauwels D, Vincent JL. Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 1999, 27:1848-1855. 10.1097/00003246-199909000-00024, 10507609.
16. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356:26-30. 10.1016/S0140-6736(00)02430-2, 10892761.
17. Honore PM, Jacobs R, Boer W, Joannes-Boyau O, De Regt J, De Waele E, et al. New insights regarding rationale, therapeutic target and dose of hemofiltration and hybrid therapies in septic acute kidney injury. Blood Purif 2012, 33:44-51. 10.1159/000333837, 22179226.
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535. 10.1136/bmj.b2535, 2714657, 19622551.
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12. 10.1016/0197-2456(95)00134-4, 8721797.
20. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P. High-volume haemofiltration in human septic shock. Intensive Care Med 2001, 27:978-986. 10.1007/s001340100963, 11497156.
21. Peng Z, Pai P, Han-Min W, Jun Z, Hong-Bao L, Rong L, et al. Evaluation of the effects of pulse high-volume hemofiltration in patients with severe sepsis: a preliminary study. Int J Artif Organs 2010, 33:505-511.
22. Schrover I, Dalhuisen A, Steenbergen H, Hofhuis J, Rommes JH, Spronk PE. Observations during high and low volume hemofiltration in septic shock patients (abstract 0153). Intensive Care Med 2009, 35:S43.
23. Borthwick EM, Hill CJ, Rabindranath KS, Maxwell AP, McAuley DF, Blackwood B. High-volume haemofiltration for sepsis. Cochrane Database Syst Rev 2013, 1. CD008075.
24. Ghani RA, Zainudin S, Ctkong N, Rahman AF, Wafa SR, Mohamad M, et al. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration. Nephrology (Carlton) 2006, 11:386-393. 10.1111/j.1440-1797.2006.00600.x, 17014550.
25. Boussekey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, et al. A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 2008, 34:1646-1653. 10.1007/s00134-008-1127-3, 18542921.
26. Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 2013, 39:1535-1546. 10.1007/s00134-013-2967-z, 23740278.
27. Sanchez C, Corbalan P, Rodriguez F, Sanchez A, Palominos S. High volume hemofiltration vs. very high volume hemofiltration: effects on hemodynamics in patients with severe sepsis: a nursing approach [Abstract]. Intensive Care Med 2010, 36:S193.
28. Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J. Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transplant 2012, 27:967-973. 10.1093/ndt/gfr486, 21891773.
29. Honore PM, Jacobs R, Joannes-Boyau O, De Regt J, De Waele E, van Gorp V, et al. Newly designed CRRT membranes for sepsis and SIRS: a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J 2013, 59:99-106. 10.1097/MAT.0b013e3182816a75, 23438770.
30. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006, 34:1589-1596. 10.1097/01.CCM.0000217961.75225.E9, 16625125.
31. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, Aldabo-Pallas T, Cayuela-Dominguez A, Marquez-Vacaro JA, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 2008, 61:436-441.
32. Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011, 26:3508-3514. 10.1093/ndt/gfr075, 21382993.
33. Schiffl H, Lang SM. Severe acute hypophosphatemia during renal replacement therapy adversely affects outcome of critically ill patients with acute kidney injury. Int Urol Nephrol 2013, 45:191-197. 10.1007/s11255-011-0112-x, 22227698.
34. Basso F, Ricci Z, Cruz D, Ronco C. International survey on the management of acute kidney injury in critically ill patients: year 2007. Blood Purif 2010, 30:214-220. 10.1159/000320126, 20948196.
35. Karvellas CJ, Farhat MR, Sajjad I, Mogensen SS, Leung AA, Wald R, et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011, 15:R72. 10.1186/cc10061, 3222005, 21352532.
36. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S, et al. Early isovolaemichaemofiltration in oliguric patients with septic shock. Intensive Care Med 2006, 32:80-86. 10.1007/s00134-005-2815-x, 16328222.
37. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28:3581-3587. 10.1097/00003246-200011000-00001, 11098957.
38. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G. Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 2004, 50:102-109. 10.1097/01.MAT.0000104846.27116.EA, 14763500.
39. Ratanarat R, Brendolan A, Piccinni P, Dan M, Salvatori G, Ricci Z, et al. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 2005, 9:R294-R302. 10.1186/cc3529, 1269433, 16137340.
40. Bellomo R, Kellum JA, Gandhi CR, Pinsky MR, Ondulik B. The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000, 161:1429-1436. 10.1164/ajrccm.161.5.9809127, 10806135.
41. Lee PA, Matson JR, Pryor RW, Hinshaw LB. Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993, 21:914-924. 10.1097/00003246-199306000-00022, 8504662.
42. Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled?. Ann Intern Med 1996, 125:605-613. 10.7326/0003-4819-125-7-199610010-00011, 8815760.
43. Brower RG, Fessler HE. Mechanical ventilation in acute lung injury and acute respiratory distress syndrome. Clin Chest Med 2000, 21:491-510. viii, 10.1016/S0272-5231(05)70161-1, 11019722.
44. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care: Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999, 340:409-417. 10.1056/NEJM199902113400601, 9971864.
45. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004, 32:21-30. 10.1097/01.CCM.0000105581.01815.C6, 14707556.
46. Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341:785-792. 10.1056/NEJM199909093411102, 10477776.
47. Honore PM, Joannes-Boyau O. High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 2004, 27:1077-1082.
48. Bellomo R, Lipcsey M, Calzavacca P, Haase M, Haase-Fielitz A, Licari E, et al. Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med 2013, 39:429-436. 10.1007/s00134-012-2800-0, 23306586.
49. Leandro G. How to interpret a randomized controlled study stopped early. Intensive Care Med 2013, 39:1642-1643. 10.1007/s00134-013-3000-2, 23797787.